(2/N) is the formula for A) . B) . C) . D) .[br][br][b][color=#FA1639]Question ...

Author Question: (2/N) is the formula for A) . B) . C) . D) .[br][br][b][color=#FA1639]Question ... (Read 104 times)

appyboo

Hero Member
Posts: 527

on: Jun 20, 2018

(2/N) is the formula for

A) .
B) .
C) .
D) .

Question 2

The variables about the people or observations within each grouping in a multilevel model are

A) upper-level variables.
B) middle-level variables.
C) lower-level variables.
D) criterion-level variables.

Viet Thy

Sr. Member
Posts: 329

Reply #1 on: Jun 20, 2018

Answer to Question 1

C

Answer to Question 2

C

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.